No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cytarabine / administration & dosage
-
DNA (Cytosine-5-)-Methyltransferases / genetics*
-
DNA Methyltransferase 3A
-
Daunorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Exons / genetics*
-
Female
-
Follow-Up Studies
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / mortality*
-
Male
-
Middle Aged
-
Mitoxantrone / administration & dosage
-
Mutation / genetics*
-
Neoplasm Staging
-
Prognosis
-
Survival Rate
Substances
-
DNMT3A protein, human
-
Cytarabine
-
Etoposide
-
Mitoxantrone
-
DNA (Cytosine-5-)-Methyltransferases
-
DNA Methyltransferase 3A
-
Daunorubicin